480 ARSENAL WAY, SUITE 100, WATERTOWN, MA
Investor Presentation
Earnings Release
Shareholder votes
Reports First Quarter 2025 Financial Results and Business Highlights
Annual Report to Security Holders
Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer
Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Definitive Revised Proxy Statement
SEC Staff Correspondence